SFPT Session 2 - Translational session: Cardiovascular, respiratory and metabolic

13:30 • SS02-01 • Nanobodies as therapeutic tools in hemostasis > C. Cécile DENIS 14:00 • 238 • Personalized Rituximab Treatment Preserves Renal Function in Membranous Nephropathy > M. Maxime TEISSEYRE 14:10 • 304 • Soft to stiff hydrogels to allow in vitro pharmacological investigations of cardiac valve remodeling > A. Ambre Raynaud 14:20 • 366 • Signal detection of adverse events associated with PCSK9 inhibitors: a sequence symmetry and disproportionality analysis > T. Thibault VIGUIER 14:30 • 413 • Blunting the peak: do proton pump inhibitors reduce lorlatinib-induced hyperlipidemia? > D. Daan Lanser 14:40 • 520 • Impact of intermittent hypoxia on clopidogrel and cytochromes in rats > C. Célian Peyronnel 14:50 • 87 • Non-inferiority of lower doses of activated charcoal for rivaroxaban antagonization: a phase 1, randomized, cross-over study > G. Giuseppe BALICE